APX001/SSS07 may be the second antibody found out through the use of Apexigen’s technologies that an IND has been filed with the SFDA. ‘We congratulate our co-workers at 3SBio on this IND filing,’ said Dr. Xiaodong Yang, President and CEO of Apexigen. ‘It represents the effort of many individuals functioning collaboratively as a team to attain the common goal. We look forward to continuing success in our collaboration.’.. 3SBio files APX001 IND software with SFDA in China Apexigen, Inc., an emerging biopharmaceutical company focused on the discovery and development of monoclonal antibody therapeutics, today that it is partner announced, 3SBio [SSRX] of Shenyang, China, filed an Investigational New Medication software for APX001, also known as SSS07, with the State Meals and Medication Administration in China.The brand new FASD clinic, on the campus of Rady Children’s Hospital-San Diego will offer you multidisciplinary specialty caution to children struggling with the disorder.
2010 TIPPS certification for Prime Therapeutics Prime Therapeutics , a thought innovator in pharmacy benefit administration, has met high criteria of pharmacy price transparency, earning it 2010 Transparency in Pharmaceutical Purchasing Requirements certification from the HR Policy Association.